October 2022 PMID 36283768

Fasting and cancer: from yeast to mammals.

Maira Di Tano, Valter D Longo

Full text PDF Download social card

Mentions

Peak: 2 in Apr 2024

across 3 sources since Oct 2022

Extended reach

42,690

potential audience

Total likes

Video views

1,085

Mentions per month

Oct 2022 – Nov 2024

Where it's discussed

YouTube4 videos
X / Twitter2 posts
News2 articles

AI synopsis

What people are saying

The discussion highlights a dismissive remark about keyword searching, which indicates limited engagement or interest overall, while a simple acknowledgment of the authors (#Maira Di Tano & Valter D Longo) suggests a recognition of the publication's relevance without much further discussion.

AgreementNeither agree nor disagree

The posts show a neutral stance, with one dismissive comment and no clear support or opposition to the publication.

InterestModerate interest

There's a modest level of curiosity, as seen in the brief mention of the article without deep analysis.

EngagementNeutral engagement

The discussion appears superficial, with little detailed interaction or elaboration on the research.

ImpactNeutral impact

The conversation seems to have minimal influence, just touching on the topic without generating significant debate or enthusiasm.

Abstract in brief

Fasting and fasting mimicking diets help increase lifespan and reduce cancer risk by causing normal cells to enter a stress-resistant state, while cancer cells with certain mutations can ignore these anti-growth signals.
Fasting enhances the effectiveness of cancer treatments like chemotherapy, radiotherapy, and targeted drugs by increasing oxidative stress and DNA damage in cancer cells, leading to their death.
Ongoing clinical trials suggest that fasting or FMD cycles are safe and may improve cancer therapy outcomes by boosting treatment efficacy and reducing side effects on healthy cells.

Read the full abstract